Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Drug Discov Devel. 2009 Mar;12(2):253-63.

    Targeting TGFbeta-mediated processes in cancer.

    Source

    Department of Biochemistry and Medical Biotechnologies, Federico II University, via Pansini 5, 80131 Naples, Italy. romano@dbbm.unina.it

    Abstract

    TGFbeta is a pleiotropic cytokine that has regulatory roles during embryonic development and adult tissue homeostasis, and is especially important for epithelial, neural and immune system differentiation and function. An increasing number of literature reports support a role for autocrine and paracrine TGFbeta-mediated processes in cancer. Progress in delineating the effects of TGFbeta in different tumors and stages of cancer has stimulated the development of TGFbeta-targeted therapies. This review describes the causes of TGFbeta malfunction in cancer, the rationale for therapeutic targeting of TGFbeta in human neoplasia, and the molecular strategies to modulate the signal.

    PMID:
    19333871
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk